Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is COMPASS Pathways PLC Sponsored ADR (CMPS) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
COMPASS Pathways PLC Sponsored ADR is a member of the Medical sector. This group includes 890 individual stocks and currently holds a Zacks Sector Rank of #6. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. COMPASS Pathways PLC Sponsored ADR is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for CMPS' full-year earnings has moved 23.4% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
According to our latest data, CMPS has moved about 32.6% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of -7.1% on a year-to-date basis. This means that COMPASS Pathways PLC Sponsored ADR is outperforming the sector as a whole this year.
Another stock in the Medical sector, DBV Technologies S.A. (DBVT), has outperformed the sector so far this year. The stock's year-to-date return is 0.9%.
For DBV Technologies S.A., the consensus EPS estimate for the current year has increased 53.4% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, COMPASS Pathways PLC Sponsored ADR belongs to the Medical Services industry, a group that includes 62 individual stocks and currently sits at #86 in the Zacks Industry Rank. On average, this group has lost an average of 11.8% so far this year, meaning that CMPS is performing better in terms of year-to-date returns.
In contrast, DBV Technologies S.A. falls under the Medical - Biomedical and Genetics industry. Currently, this industry has 435 stocks and is ranked #96. Since the beginning of the year, the industry has moved +0.4%.
Investors interested in the Medical sector may want to keep a close eye on COMPASS Pathways PLC Sponsored ADR and DBV Technologies S.A. as they attempt to continue their solid performance.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
COMPASS Pathways PLC Sponsored ADR (CMPS): Free Stock Analysis Report
DBV Technologies S.A. (DBVT): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).